Abeona Therapeutics (ABEO) Current Assets (2010 - 2026)

Abeona Therapeutics' Current Assets history runs 17 years deep, the most recent figure standing at $183.0 million for Q1 2026.

• On a quarterly basis, Current Assets rose 107.65% year-over-year to $183.0 million in Q1 2026; TTM through Mar 2026 was $183.0 million, a 107.65% increase from a year earlier, with the FY2025 full-year figure at $204.9 million, up 103.17% from the prior year.
• Current Assets retreated to $183.0 million in Q1 2026 per ABEO's latest filing, from $204.9 million in the prior quarter.
• Across five years, Current Assets topped out at $232.3 million in Q2 2025 and bottomed at $25.5 million in Q3 2022.
• The 5-year median for Current Assets is $66.7 million (2024), against an average of $98.7 million.
• Across the five-year window, Current Assets sank 62.45% in 2022 and soared 185.9% in 2024, its largest moves.
• Year by year, Current Assets stood at $53.1 million in 2022, then gained by 4.97% to $55.7 million in 2023, then jumped by 80.94% to $100.9 million in 2024, then surged by 103.17% to $204.9 million in 2025, then fell by 10.7% to $183.0 million in 2026.
• Per Business Quant, the three latest ABEO Current Assets figures stand at $183.0 million (Q1 2026), $204.9 million (Q4 2025), and $216.1 million (Q3 2025).